Gallagher Neil (CIK 1972849) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-12). Recent activity: Sell SNDX (4,618 shares), Buy SNDX (18,500 shares), Buy SNDX (23,400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-12 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of R&D | Sell | 4,618 | $71,579 |
| 2025-02-07 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of R&D | Buy | 18,500 | $0 |
| 2025-02-07 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of R&D | Buy | 23,400 | $0 |
Source: SEC Form 4 filings · as of 2025-02-12